Triplex International Biosciences (China) Co., Ltd,

Founded in 2004 with a registered capital of US$ 130 million, Triplex International Biosciences (China) Co., Ltd. (TIB) is a high-tech biomedical enterprise which integrates R&D, production and sales of molecular diagnosis and the supporting instruments as well as high-end medical diagnosis services. TIB has obtained more than 60 registration certificates for its in-vitro diagnostic reagent (IVD) products, as well as the production and business licenses, from CFDA. TIB`s products are mainly used for the diagnosis of tumors, infectious diseases, genetic diseases and heart diseases. Among them, techniques for fluorescent PCR based diagnostic kits, such as diagnostic kits for Group B Streptococcus, Staphylococcus aureus and its drug resistance counterpart, deep fungi and others, have reached the international advanced level and the leading domestic level. TIB also provides overall diagnostic solution for gynecological disease and Eugenics.